PD-L1 expression in tumour buds of colorectal carcinoma

Histopathology

Volumn 69, Issue 1, 2016, Pages 158-160

  Prall, Friedrich ^a   Hühns, Maja ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1;

CANCER CLASSIFICATION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CARCINOMA CELL; COLORECTAL CANCER; COLORECTAL CARCINOMA; FIBROBLAST; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LETTER; MACROPHAGE; MICROSATELLITE INSTABILITY; PATHOLOGIST; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 84974711217     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12915     Document Type: Letter

References (5)

1. Herbst RS, Soria JC, Kowanetz M et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014; 515; 563–567.
2. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 2015; 372; 2509–2520.
3. Llosa NJ, Cruise M, Tam A et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015; 5; 43–51.
4. Van den Brand M, Hoevenaars BM, Sigmans JHM et al. Sequential immunohistochemistry: a promising new tool for the pathology laboratory. Histopathology 2014; 65; 651–657.
5. Teng MWL, Ngiow SF, Ribas A, Smyth MJ. Classifying cancers based on T-cell infiltration and PD-L1. Cancer Res. 2015; 75; 2139–2145.